
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chlorotrianisene,Doxorubicin Hydrochloride,Epirubicin Hydrochloride,Fluorouracil,Mitomycin,Gemcitabine,Cisplatin
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Accuray
Deal Size : Inapplicable
Deal Type : Inapplicable
Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
Details : TACE is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Carcinoma, Hepatocellular.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 01, 2011
Lead Product(s) : Chlorotrianisene,Doxorubicin Hydrochloride,Epirubicin Hydrochloride,Fluorouracil,Mitomycin,Gemcitabine,Cisplatin
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Accuray
Deal Size : Inapplicable
Deal Type : Inapplicable
